Algo version: 0.98b
Morepen Laboratories is listed at the NSE Exchange
Morepen Laboratories [MOREPENLAB.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Morepen Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Morepen Laboratories pays dividends. Last time was Tuesday 8th of October 2002 where the investors holding the stock on Wednesday 18th of September 2002 were paid INR0.6 per share. Over the last 5 times between 2000 and 2002, Morepen Laboratories has paid INR4.8 with an average of INR0.96 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Morepen Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR16.60, you would have made a profit of INR72.75 per share or 438.25%

Yes, the average daily trading liquidity for Morepen Laboratories is INR19.35 million. You should therefore be able to get in and out of your positions relatively fast.

Morepen Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.64, the company's ability to pay off the debt is good. The company has a very low net profit margin of 4.68%, which is challenging.

We have calculated the inflation risk for Morepen Laboratories to be low [0.2 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.